The Uromigos
Podcast autorstwa The Uromigos
401 Odcinki
-
Episode 183: Oliver Sartor - The Uromigos Legends Series
Opublikowany: 18.07.2022 -
Episode 182: ASCO Kidney Cancer Guidelines
Opublikowany: 11.07.2022 -
Episode 181: Relapsed Germ Cell Tumours
Opublikowany: 27.06.2022 -
Episode 180: Enzalutamide vs active surveillance in early prostate cancer
Opublikowany: 20.06.2022 -
Episode 179: PSMA PET for Lutetium-177 in prostate cancer
Opublikowany: 20.06.2022 -
Episode 178: ASCO 2022: Germline variants in men of African descent with prostate cancer
Opublikowany: 7.06.2022 -
Episode 177: ASCO 2022: ENZAMET survival update
Opublikowany: 5.06.2022 -
Episode 176: ASCO 2022: HER-2 ADCs in Bladder Cancer
Opublikowany: 5.06.2022 -
Episode 175: ASCO 2022: Targeting the microbiome in renal cancer
Opublikowany: 4.06.2022 -
Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer
Opublikowany: 3.06.2022 -
Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer
Opublikowany: 3.06.2022 -
Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer
Opublikowany: 3.06.2022 -
Episode 171: Antibody drug conjugates in bladder cancer: managing adverse effects
Opublikowany: 23.05.2022 -
Episode 170: APCCC Meeting Summary
Opublikowany: 16.05.2022 -
Episode 169: The Uromigos Paper of the Month - Novel neoadjuvant approaches in UC
Opublikowany: 9.05.2022 -
Episode 168: Mechanisms of response to PD1 therapy in renal cancer
Opublikowany: 2.05.2022 -
Episode 167: Highlights from EIKCS oral session
Opublikowany: 22.04.2022 -
Episode 166: Prostate cancer debate: doublet vs triplet first line therapy
Opublikowany: 18.04.2022 -
Episode 165: Paper of the Month - ENZAMET quality of life data
Opublikowany: 6.04.2022 -
Episode 164: Paper of the Month - what can we learn from R3 ipilimumab/nivolumab in gastric cancer
Opublikowany: 1.04.2022
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
